351 related articles for article (PubMed ID: 12724320)
1. Identification of p2y9/GPR23 as a novel G protein-coupled receptor for lysophosphatidic acid, structurally distant from the Edg family.
Noguchi K; Ishii S; Shimizu T
J Biol Chem; 2003 Jul; 278(28):25600-6. PubMed ID: 12724320
[TBL] [Abstract][Full Text] [Related]
2. Non-Edg family lysophosphatidic acid (LPA) receptors.
Ishii S; Noguchi K; Yanagida K
Prostaglandins Other Lipid Mediat; 2009 Sep; 89(3-4):57-65. PubMed ID: 19524700
[TBL] [Abstract][Full Text] [Related]
3. Ki16425, a subtype-selective antagonist for EDG-family lysophosphatidic acid receptors.
Ohta H; Sato K; Murata N; Damirin A; Malchinkhuu E; Kon J; Kimura T; Tobo M; Yamazaki Y; Watanabe T; Yagi M; Sato M; Suzuki R; Murooka H; Sakai T; Nishitoba T; Im DS; Nochi H; Tamoto K; Tomura H; Okajima F
Mol Pharmacol; 2003 Oct; 64(4):994-1005. PubMed ID: 14500756
[TBL] [Abstract][Full Text] [Related]
4. Strategy for the identification of GPR23/LPA4 receptor agonists and inverse agonists.
Wong SH; Mallari R; Graham M; Atangan L; Lu SC; Zhao X; Gu W; Lee PH
Assay Drug Dev Technol; 2010 Aug; 8(4):459-70. PubMed ID: 20482379
[TBL] [Abstract][Full Text] [Related]
5. Role of LPA4/p2y9/GPR23 in negative regulation of cell motility.
Lee Z; Cheng CT; Zhang H; Subler MA; Wu J; Mukherjee A; Windle JJ; Chen CK; Fang X
Mol Biol Cell; 2008 Dec; 19(12):5435-45. PubMed ID: 18843048
[TBL] [Abstract][Full Text] [Related]
6. Non-Edg family LPA receptors: the cutting edge of LPA research.
Yanagida K; Ishii S
J Biochem; 2011 Sep; 150(3):223-32. PubMed ID: 21746769
[TBL] [Abstract][Full Text] [Related]
7. LPA4/p2y9/GPR23 mediates rho-dependent morphological changes in a rat neuronal cell line.
Yanagida K; Ishii S; Hamano F; Noguchi K; Shimizu T
J Biol Chem; 2007 Feb; 282(8):5814-24. PubMed ID: 17172642
[TBL] [Abstract][Full Text] [Related]
8. Molecular cloning and characterization of a novel human G-protein-coupled receptor, EDG7, for lysophosphatidic acid.
Bandoh K; Aoki J; Hosono H; Kobayashi S; Kobayashi T; Murakami-Murofushi K; Tsujimoto M; Arai H; Inoue K
J Biol Chem; 1999 Sep; 274(39):27776-85. PubMed ID: 10488122
[TBL] [Abstract][Full Text] [Related]
9. LPA(4)/GPR23 is a lysophosphatidic acid (LPA) receptor utilizing G(s)-, G(q)/G(i)-mediated calcium signaling and G(12/13)-mediated Rho activation.
Lee CW; Rivera R; Dubin AE; Chun J
J Biol Chem; 2007 Feb; 282(7):4310-4317. PubMed ID: 17166850
[TBL] [Abstract][Full Text] [Related]
10. Structural insights into ligand recognition by the lysophosphatidic acid receptor LPA
Taniguchi R; Inoue A; Sayama M; Uwamizu A; Yamashita K; Hirata K; Yoshida M; Tanaka Y; Kato HE; Nakada-Nakura Y; Otani Y; Nishizawa T; Doi T; Ohwada T; Ishitani R; Aoki J; Nureki O
Nature; 2017 Aug; 548(7667):356-360. PubMed ID: 28792932
[TBL] [Abstract][Full Text] [Related]
11. Naturally occurring analogs of lysophosphatidic acid elicit different cellular responses through selective activation of multiple receptor subtypes.
Fischer DJ; Liliom K; Guo Z; Nusser N; Virág T; Murakami-Murofushi K; Kobayashi S; Erickson JR; Sun G; Miller DD; Tigyi G
Mol Pharmacol; 1998 Dec; 54(6):979-88. PubMed ID: 9855625
[TBL] [Abstract][Full Text] [Related]
12. Novel clusters of receptors for sphingosine-1-phosphate, sphingosylphosphorylcholine, and (lyso)-phosphatidic acid: new receptors for "old" ligands.
Kostenis E
J Cell Biochem; 2004 Aug; 92(5):923-36. PubMed ID: 15258916
[TBL] [Abstract][Full Text] [Related]
13. Toward the three-dimensional structure and lysophosphatidic acid binding characteristics of the LPA(4)/p2y(9)/GPR23 receptor: a homology modeling study.
Li G; Mosier PD; Fang X; Zhang Y
J Mol Graph Model; 2009 Aug; 28(1):70-9. PubMed ID: 19423373
[TBL] [Abstract][Full Text] [Related]
14. Functional comparisons of the lysophosphatidic acid receptors, LP(A1)/VZG-1/EDG-2, LP(A2)/EDG-4, and LP(A3)/EDG-7 in neuronal cell lines using a retrovirus expression system.
Ishii I; Contos JJ; Fukushima N; Chun J
Mol Pharmacol; 2000 Nov; 58(5):895-902. PubMed ID: 11040035
[TBL] [Abstract][Full Text] [Related]
15. Phosphorothioate analogues of alkyl lysophosphatidic acid as LPA3 receptor-selective agonists.
Qian L; Xu Y; Simper T; Jiang G; Aoki J; Umezu-Goto M; Arai H; Yu S; Mills GB; Tsukahara R; Makarova N; Fujiwara Y; Tigyi G; Prestwich GD
ChemMedChem; 2006 Mar; 1(3):376-83. PubMed ID: 16892372
[TBL] [Abstract][Full Text] [Related]
16. Lysophosphatidic acid receptor 4 signaling potentially modulates malignant behavior in human head and neck squamous cell carcinoma cells.
Matayoshi S; Chiba S; Lin Y; Arakaki K; Matsumoto H; Nakanishi T; Suzuki M; Kato S
Int J Oncol; 2013 May; 42(5):1560-8. PubMed ID: 23467751
[TBL] [Abstract][Full Text] [Related]
17. Aberrant expression of lysophosphatidic acid (LPA) receptors in human colorectal cancer.
Shida D; Watanabe T; Aoki J; Hama K; Kitayama J; Sonoda H; Kishi Y; Yamaguchi H; Sasaki S; Sako A; Konishi T; Arai H; Nagawa H
Lab Invest; 2004 Oct; 84(10):1352-62. PubMed ID: 15220934
[TBL] [Abstract][Full Text] [Related]
18. A growing family of receptor genes for lysophosphatidic acid (LPA) and other lysophospholipids (LPs).
Chun J; Contos JJ; Munroe D
Cell Biochem Biophys; 1999; 30(2):213-42. PubMed ID: 10356643
[TBL] [Abstract][Full Text] [Related]
19. Sphingosine 1-phosphate signalling through the G-protein-coupled receptor Edg-1.
Zondag GC; Postma FR; Etten IV; Verlaan I; Moolenaar WH
Biochem J; 1998 Mar; 330 ( Pt 2)(Pt 2):605-9. PubMed ID: 9480864
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6.
Yanagida K; Masago K; Nakanishi H; Kihara Y; Hamano F; Tajima Y; Taguchi R; Shimizu T; Ishii S
J Biol Chem; 2009 Jun; 284(26):17731-41. PubMed ID: 19386608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
